Adherence to Phosphate Binder Therapy Is the Primary Determinant of Hyperphosphatemia Incidence in Patients Receiving Peritoneal Dialysis
| Autor: | Jin-Bor Chen, Kai-Yin Hung, Shang-Chih Liao, Tzu-Hsiu Chen, Mei-Chen Chao |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Demographics business.industry medicine.drug_class medicine.medical_treatment Incidence (epidemiology) Retrospective cohort study Hematology Phosphate medicine.disease Gastroenterology Surgery Peritoneal dialysis Phosphate binder chemistry.chemical_compound Hyperphosphatemia chemistry Nephrology Internal medicine medicine In patient business |
| Zdroj: | Therapeutic Apheresis and Dialysis. 17:72-77 |
| ISSN: | 1744-9979 |
| Popis: | We investigated the major determinant of hyperphosphatemia incidence among patients receiving peritoneal dialysis. Seventy-six patients aged 25-55 years who had received peritoneal dialysis for more than 3 months were recruited. The patients were divided into three groups according to their serum phosphorus levels (Group 1, ≥ 6 mg/dL; Group 2, 5.9-4.8 mg/dL; and Group 3 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text